ITGR
Integer Holdings Corp
NYSE · Healthcare · Medical - Devices · US
$126.59
+0.06%Year over year
Reported trailing growth
- Revenue
- -0.0%
- EBITDA
- -2.4%
- EBIT
- -30.7%
- EPS
- +20.0%
- Free cash flow
- -32.6%
- Operating cash flow
- -13.5%
Forward estimates
Based on analyst estimates
- Revenue
- +3.7%
- EBITDA
- +51.6%
- EPS
- +125.8%
Three-year CAGR
- Revenue
- +11.5%
- EBITDA
- +10.2%
- EBIT
- +22.9%
- Net income
- +15.7%
- EPS
- +14.5%
- Free cash flow
- +36.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Oct 1, 2026